Group 3 for Wound Healing
Phase-Based Progress Estimates
Effectiveness
Safety
University of Texas Health Science Center at San Antonio (Dental School), San Antonio, TX
Wound Healing+2 More
Vallos-F - DeviceEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers.
Eligible Conditions
- Wound Healing
- Dental Extraction
Treatment Effectiveness
Effectiveness Progress
Other trials for Wound Healing
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: Baseline to 18-20 weeks
Baseline to 18-20 weeks
Change in buccal ridge height
Change in lingual ridge height
Change in ridge width
Week 20
Percentage of connective tissue
Percentage of residual graft material
Percentage vital bone formation
Trial Safety
Safety Progress
Other trials for Wound Healing
Trial Design
8 Treatment Groups
Group 3
1 of 8
Group 4
1 of 8
Group 2
1 of 8
Group 1
1 of 8
Group 4 Vallomix-F
1 of 8
Group 2 Vallomix
1 of 8
Group 3 Vallos-F
1 of 8
Group 1 Vallos
1 of 8
Active Control
120 Total Participants · 8 Treatment Groups
Primary Treatment: Group 3 · No Placebo Group · N/A
Group 3
Device
ActiveComparator Group · 1 Intervention: Vallos-F · Intervention Types: DeviceGroup 4
Device
ActiveComparator Group · 1 Intervention: Vallomix-F · Intervention Types: DeviceGroup 2
Device
ActiveComparator Group · 1 Intervention: Vallomix · Intervention Types: DeviceGroup 1
Device
ActiveComparator Group · 1 Intervention: Vallos · Intervention Types: DeviceGroup 4 Vallomix-F
Device
ActiveComparator Group · 1 Intervention: Vallomix-F · Intervention Types: DeviceGroup 2 Vallomix
Device
ActiveComparator Group · 1 Intervention: Vallomix · Intervention Types: DeviceGroup 3 Vallos-F
Device
ActiveComparator Group · 1 Intervention: Vallos-F · Intervention Types: DeviceGroup 1 Vallos
Device
ActiveComparator Group · 1 Intervention: Vallos · Intervention Types: DeviceTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 18-20 weeks
Closest Location: University of Texas Health Science Center at San Antonio (Dental School) · San Antonio, TX
2013First Recorded Clinical Trial
1 TrialsResearching Wound Healing
1 CompletedClinical Trials
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:One tooth, excluding molars, that has been identified by dental faculty as requiring a single tooth extraction.
A dental implant is indicated and treatment planned to replace the missing tooth.
You have adequate restorative space for a dental implant-retained restoration.
You have a dehiscence of the buccal or lingual bony plate of the tooth socket extending no more than 50% of the total depth of the socket.
You are female and of child-bearing potential.
You are a current smoker or a former smoker.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments